Cystic Fibrosis News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
U.S. Food And Drug Administration Approves Cayston(R) For The Improvement Of Respiratory Symptoms In Cystic Fibrosis Patients
Gilead Sciences, Inc. (Nasdaq:GILD) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston(R)(aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa (P. aeruginosa)...
Aradigm Doses First Patient In Its Second Phase 2b Clinical Trial Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis Patients
Aradigm Corporation (OTCBB:ARDM) (the "Company") announced that it dosed the first patient in the U.S...
PARI Pharma's Altera Delivers Gilead's Cayston, Approved By The U.S. FDA For The Improvement Of Respiratory Symptoms In Cystic Fibrosis Patients
Altera, which uses eFlow Technology, was cleared to market by the FDA as the first drug-specific nebulizer for use in the treatment of patients with cystic fibrosis and has been specifically developed to deliver Gilead Sciences' Cayston (aztreonam for inhalation solution) 75 mg. Cayston is a new inhaled antibiotic that received marketing approval from the U.S...
FDA Approves First New Inhaled Antibiotic For CF In More Than A Decade
The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis. The drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $1 million investment by a Foundation subsidiary to help develop the therapy. Developed by Gilead Sciences, Inc...
Cases Of Some Genetic Diseases Appear To Decline As Prenatal Testing, Embryonic Screenings Increase
As prenatal and embryonic genetic testing has become more widespread in the U.S., the number of infants with certain inheritable diseases -- such as cystic fibrosis, Tay-Sachs and familial dysautonomia -- has declined, according to an Associated Press review of research and interviews with genetics experts, the AP/Seattle Times reports...
Low-Cost DNA Test To Pinpoint Risk Of Inherited Diseases
An inexpensive, fast, accurate DNA test that reveals a person's risk of developing certain diseases is expected to become a reality, thanks to technology developed at the University of Edinburgh. Scientists have developed a method of pinpointing variations in a person's genetic code at critical points along the DNA chain. The technique could be used to analyse DNA in a drop of saliva...
Defective Signaling Pathway Sheds Light On Cystic Fibrosis
In a study that could lead to new therapeutic targets for patients with the cystic fibrosis, a research team from the University of California, San Diego School of Medicine has identified a defective signaling pathway that contributes to disease severity...
Cystic Fibrosis Foundation Receives $521,000 From BJ's Restaurants, Inc., As Part Of Long-Term Commitment To Fight Life-Threatening Disease
As part of a steadfast commitment to finding a cure for cystic fibrosis, BJ's Restaurants, Inc. donated $521,000 to the Cystic Fibrosis Foundation in 2009 for research, care and education programs. BJ's has been involved with the Foundation since 1998 and is one of its largest and most loyal corporate supporters...
CREON(R) (pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption In Children With Cystic Fibrosis
Solvay Pharmaceuticals, Inc...
Cystic Fibrosis Foundation Volunteer To Carry Torch For Vancouver 2010 Olympic Winter Games
One of the Cystic Fibrosis Foundation's most active volunteers will carry the Olympic Torch today in Calgary as it makes its way to Vancouver and the Opening Ceremony for the 2010 Olympic Winter Games. Liz Burns, incoming board president for the Foundation's Georgia Chapter, has helped raise more than $600,000 for CF research, care and education programs...
Biodegradable Particles Can Bypass Mucus, Release Drugs Over Time
Johns Hopkins University researchers have created biodegradable nanosized particles that can easily slip through the body's sticky and viscous mucus secretions to deliver a sustained-release medication cargo...
Glycyrrhizin Extracted From Licorice Root Helps The Body Defend Against Pseudomonas Aeruginosa Infection Following Severe Burns
As it turns out, children were not the only ones with visions of sugar plums dancing in their heads over this past holiday season...
Disinfectants May Help Superbugs Resist Antibiotics
Using disinfectants could help superbug bacteria become resistant not only to the disinfectant itself but to antibiotics, even if they have not been exposed to them, according to a new study from Ireland: the findings could be important step in the fight to prevent superbugs spreading in hospitals...
$1.4 Million Grant Received By Boston University School Of Medicine
Boston University School of Medicine's (BUSM) Pulmonary Center has received a two-year $1.4 million grant from the National Heart, Lung, and Blood Institute to derive stem cells and lung progenitors from patients with lung disease...
Carrier Screening Associated With Decrease In Incidence Of Cystic Fibrosis
An increase in the number of screened carriers for cystic fibrosis (CF) was associated with a decrease in the number of children born with CF in northeast Italy, according to a study in the December 16 issue of JAMA. Some studies have suggested that there has been a progressive decrease in the incidence of newborns with CF in some areas...
Cystic Fibrosis Protein's Secret Life Revealed, US Study
Researchers have made an important discovery about the secret life of the defective protein that causes cystic fibrosis: while scientists already knew that CFTR protein regulates the acid-alkali balance in cells, what they didn't know, until this study revealed it, was what turns that ability on and off...
Improved Understanding Of The Defective Protein That Causes Cystic Fibrosis
A team of researchers studying the protein that, when defective or absent, causes cystic fibrosis (CF) has made an important discovery about how that protein is normally controlled and under what circumstances it might go awry...
A Scaffold Regulating Protein Disposal Identified By MDC Researchers
How does a cell manage to identify and degrade the diverse types of defective proteins and thus protect the body against serious diseases? The researchers Sabine C. Horn, Professor Thomas Sommer, Professor Udo Heinemann and Dr. Ernst Jarosch of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now found a crucial piece in this puzzle...
FDA Advisory Committee Supports Use Of Aztreonam For Inhalation Solution For Patients With Cystic Fibrosis
Gilead Sciences, Inc. (Nasdaq: GILD) announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF)...
Some Function Restored To Cells From Cystic Fibrosis Patients By Scripps Research Team
In an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before the therapy can be tested in humans, the discovery opens the door to a new class of therapies for this and a host of other chronic diseases...
Genta To Support Initiation Of New Clinical Trial Using Ganite(R) As Treatment For Life-Threatening Infections In Patients With Cystic Fibrosis
Genta Incorporated (OTCBB: GETA) announced that the Company will supply Ganite® (gallium nitrate injection) for a new clinical trial that will be initiated in patients with cystic fibrosis (CF) who may develop serious infections. Infection is the most common cause of death in CF patients...
Eurand Launches ZENPEPTM (Pancrelipase) Delayed-Release Capsules
Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced the commercial availability of ZENPEPâ„¢ (pancrelipase) Delayed-Release Capsules, a pancreatic enzyme product (PEP) indicated for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF) or other conditions. The U.S. Food and Drug Administration (FDA) approved ZENPEP on August 27, 2009...
The Cystic Fibrosis Foundation To Benefit From Holiday Film Promotion
The Cystic Fibrosis Foundation announced today that CVS/pharmacy and Warner Home Video will partner with the Foundation this holiday season to raise critical funds for cystic fibrosis through the sale of classic family movies. The videos will be sold exclusively at CVS/pharmacy...
Exome-Sequencing Might Help Identify Genetic Cause Of Thousands Of Disorders
For the first time, scientists have successfully used a method called exome sequencing to quickly discover a previously unknown gene responsible for a mendelian disorder. Mendelian disorders, such as cystic fibrosis and sickle cell disease, are the result of one or more mutations in a single gene, typically a gene that makes a protein...
Antioxidant Found In Vegetables Has Implications For Treating Cystic Fibrosis
Scientists at the University of Pennsylvania School of Medicine discovered that a dietary antioxidant found in such vegetables as broccoli and cauliflower protects cells from damage caused by chemicals generated during the body's inflammatory response to infection and injury...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
